viral
infect
probabl
initi
larg
percentag
childhood
adult
asthmat
attack
base
histori
preced
cold
high
rate
viral
isol
attack
lower
rate
isol
symptomfre
interv
peak
hospit
admiss
asthma
coincid
viral
epidem
although
pcr
technolog
provid
much
sensit
specif
method
detect
viral
nucleic
acid
role
diagnos
activ
viral
infect
partial
explor
purpos
chapter
present
preliminari
find
use
pcr
screen
procedur
common
respiratori
virus
review
data
concern
possibl
role
latent
infect
adenoviru
persist
viral
infect
respiratori
syncyti
viru
rsv
pathogenesi
chronic
lung
inflamm
pcr
screen
procedur
nine
common
respiratori
virus
perform
lung
tissu
obtain
asthmat
nonasthmat
patient
lung
histolog
immunohistochemistri
inflammatori
reaction
case
subject
recent
report
six
addit
case
four
lifetim
nonsmok
two
remot
minim
smoke
histori
ad
control
fact
asthmat
nonasthmat
smoke
heavili
use
data
two
virus
adenoviru
rsv
discuss
possibl
role
latent
persist
viral
infect
pathogenesi
chronic
lung
inflamm
age
sex
smoke
histori
evid
preoper
infect
avail
lung
function
patient
lung
tissu
obtain
summar
tabl
subject
select
lung
transplant
donor
remain
case
surgic
patient
underw
lung
resect
tumour
part
longterm
studi
lung
structur
function
base
st
paul
hospit
vancouv
enter
patient
sinc
review
hospit
record
identifi
six
surgic
case
flulik
ill
sever
cold
week
prior
surgeri
lung
tissu
process
use
method
previous
describ
detail
briefli
resect
specimen
allow
collaps
tumour
palpat
pleural
surfac
bisect
sampl
histolog
region
lymph
node
dissect
bronchial
resect
margin
sampl
obtain
materi
need
complet
standard
surgic
patholog
report
incis
made
pleural
surfac
sutur
close
lung
fill
cryoprotect
agent
suspend
liquid
nitrogen
aluminium
foil
close
styrofoam
contain
frozen
solid
frozen
lung
cut
cm
thick
slice
band
saw
transvers
plane
slice
kept
frozen
dri
ice
sampl
powerdriven
hole
saw
core
tissu
obtain
procedur
store
use
lung
specimen
obtain
autopsi
process
similar
manner
without
necess
cut
pleural
surfac
fragment
obtain
core
frozen
tissu
homogen
use
polytron
probe
rna
extract
homogen
use
rneasi
kit
qiagen
gmbh
germani
overnight
tissu
digest
digest
buffer
contain
gml
proteinas
k
sampl
trizol
gibco
brl
burlington
ontario
canada
sampl
dna
extract
use
qia
amp
tissu
kit
qiagen
gmbh
germani
overnight
digest
buffer
contain
proteinas
k
rna
extract
tissu
homogen
revers
transcrib
hour
reaction
consist
mm
tri
ph
mm
mm
dntp
unit
rnaas
inhibitor
rnaguard
pharmacia
g
random
hexam
pharmacia
unit
clone
moloney
murin
leukaemia
viru
revers
transcriptas
gibco
brl
cdna
product
revers
transcript
reaction
fraction
extract
dna
case
adenoviru
subsequ
use
amplif
pcr
contain
mm
tri
ph
mm
mm
dntp
unit
taq
dna
polymeras
gibco
brl
pmol
upstreamand
downstreamspecif
primer
tabl
ii
sampl
subject
denatur
minut
follow
cycl
amplif
thermal
stratagen
la
jolla
ca
usa
cycl
consist
denatur
minut
anneal
minut
extens
minut
last
cycl
extens
minut
amplif
pcr
product
resolv
electrophoresi
ethidium
bromidestain
agaros
gel
adenoviru
amplifi
product
reamplifi
nest
primer
reaction
mixtur
result
product
underw
electrophoresi
agaros
gel
ethidium
bromidestain
dna
visual
ultraviolet
light
control
pcr
reaction
consist
nucleic
acid
extract
virusinfect
cell
cultur
follow
virus
obtain
american
type
cultur
collect
atcc
rockvil
md
usa
rsv
long
strain
type
human
rhinoviru
hrv
type
b
coronaviru
subtyp
influenza
influenza
influenza
ctaylor
adenoviru
serotyp
rsv
grown
atcc
cell
monolay
minim
essenti
medium
mem
supplement
fetal
bovin
serum
fb
hrv
grown
atcc
cell
monolay
eagl
basal
medium
contain
fb
influenza
coronavirus
grown
monkey
kidney
cell
monolay
medium
supplement
hors
serum
hyclon
logan
ut
usa
influenza
virus
trypsin
ad
cultur
adenoviru
serotyp
grown
monolay
cell
mem
fb
cultur
media
contain
gml
gentamicin
assess
success
dna
extract
examin
lantitrypsin
gene
rna
extract
theactin
rna
examin
tabl
tabl
iii
ii
integr
extract
rna
difficult
assess
amplif
cdna
cytoplasm
mrna
transcript
housekeep
gene
actin
confus
amplif
correspond
pseudogen
dna
contamin
sampl
altern
measur
base
qualiti
rna
sampl
integr
ribosom
rna
sampl
determin
appear
agaros
gel
tabl
iii
summar
featur
specif
primer
probe
use
studi
except
primer
probe
influenza
c
design
genbank
sequenc
previous
publish
reagent
prepar
use
autom
dna
synthes
commerci
sourc
univers
calgari
calgari
alberta
canada
primer
select
hrv
also
detect
picornavirus
use
adenoviru
detect
serotyp
viru
viral
contamin
nucleic
acid
extract
control
simultan
extract
porcin
lung
tissu
known
free
human
viral
agent
tube
contain
diethylpyrocarbon
depc
water
instead
nucleic
acid
ad
everi
sampl
pcr
run
ensur
contamin
occur
step
southern
transfer
hybondn
nylon
membran
amersham
arlington
height
il
usa
crosslink
ultraviolet
light
pcr
product
hybrid
oligonucleotid
probe
endlabel
atp
use
polynucleotid
kinas
gibco
brl
follow
manufactur
instruct
hybrid
carri
hybaid
hybrid
oven
stratagen
hour
solut
consist
sodium
chloridesodium
citrat
ssc
sodium
citrat
ph
x
dernhardt
solut
bovin
serum
albumin
fraction
v
polyvinylpyrrolidon
sodium
dodecyl
sulfat
fragment
salmon
sperm
dna
hybrid
membran
wash
three
time
minut
x
ssc
room
temperatur
minut
exposur
kodak
xray
film
proport
posit
total
case
tabul
viru
differ
relat
asthma
smoke
infect
statu
examin
use
fisher
exact
test
correct
multipl
comparison
tabl
show
age
sex
distribut
smoke
histori
histori
recent
infect
minim
smoker
ms
n
asthmat
n
nonasthmat
n
group
asthmat
moder
smoker
averag
histori
cigarett
year
approxim
pack
year
consumpt
smoke
group
without
asthma
tend
higher
exposur
cigarett
year
approxim
pack
year
exposur
reach
statist
signific
wide
varianc
subject
group
lowest
cigarett
exposur
contain
four
lifetim
nonsmok
two
case
minim
remot
smoke
histori
avail
lung
function
group
littl
smoke
histori
within
normal
limit
statist
signific
differ
lung
function
patient
smoker
either
asthma
figur
show
repres
autoradiograph
agaros
gel
contain
result
pcr
analysi
sampl
plu
posit
neg
control
viru
test
data
show
rsv
influenza
influenza
c
adenoviru
preval
virus
case
case
except
number
contain
least
one
viru
sever
contain
one
case
contain
nucleic
acid
four
virus
tabl
iv
one
viru
detect
case
two
found
six
case
three
four
case
four
three
case
statist
signific
differ
proport
posit
test
viru
asthmat
smoke
ms
control
group
p
also
differ
either
number
type
viru
detect
case
clinic
episod
suggest
recent
infect
case
tabl
remaind
case
studi
p
infect
tissu
viru
involv
adher
viru
host
cell
penetr
cell
replic
viral
nucleic
acid
product
structur
protein
assembl
complet
viru
releas
assembl
viru
host
cell
either
shed
cell
surfac
host
cell
lysi
test
requir
establish
step
occur
includ
cultur
document
viral
replic
situ
hybrid
pcr
detect
viral
nucleic
acid
immunocytochemistri
immunohistochemistri
demonstr
viral
protein
electron
microscopi
establish
complet
viru
assembl
chang
usual
associ
seroconvers
host
indic
immun
respons
viru
data
base
sole
pcr
viral
nucleic
acid
must
interpret
cautious
demonstr
viral
nucleic
acid
necessarili
mean
result
cultur
situ
hybrid
immunohistochemistri
electron
microscopi
also
posit
previou
pcrbase
studi
laboratori
show
excel
concord
cultur
pcr
sampl
cultur
posit
case
pcr
result
frequent
show
presenc
one
type
viral
nucleic
acid
wherea
cultur
rare
show
presenc
one
replic
viru
result
report
fig
tabl
iv
establish
nucleic
acid
sever
respiratori
virus
present
lower
respiratori
tract
subject
six
patient
undergo
lung
resect
gave
histori
flulik
ill
upper
respiratori
infect
week
prior
surgeri
other
may
asymptomat
infect
differ
either
number
type
viru
detect
group
without
symptomat
ill
replic
viru
shed
upper
airway
day
follow
acut
infect
viral
nucleic
acid
may
remain
long
viru
ceas
replic
recent
anim
studi
report
laboratori
shown
rsv
demonstr
cultur
two
month
infect
rtpcr
four
month
acut
infect
pcr
shown
similar
result
guinea
pig
adenovir
bronchiol
much
difficult
establish
viral
persist
human
mani
respiratori
virus
sever
serotyp
infect
differ
serotyp
could
easili
mistaken
persist
exampl
screen
use
adenoviru
studi
base
sequenc
hexon
protein
common
adenovir
serotyp
make
sensit
test
presenc
adenoviru
use
test
persist
adenovir
infect
differenti
serotyp
acut
viral
infect
respiratori
tract
caus
prolong
increas
bronchial
reactiv
asthmat
patient
might
result
previou
sensit
host
viral
protein
lytic
infect
reinforc
sensit
protein
produc
either
persist
low
level
replic
viru
express
latent
viral
gene
remain
replic
ceas
import
host
respons
illustr
earli
attempt
develop
rsv
vaccin
fatal
bronchiol
sometim
occur
vaccin
children
next
expos
wild
type
viru
recent
studi
healthi
individu
infect
rhinoviru
show
sever
upper
respiratori
infect
could
diminish
administr
neutral
antibodi
nonatop
subject
without
effect
atop
subject
report
suppress
viral
induc
asthmat
attack
prolong
viral
shed
anim
parainfluenza
viru
infect
receiv
corticosteroid
therapi
consist
symptom
caus
respons
viru
rather
direct
tissu
damag
caus
viru
concept
support
recent
report
show
airway
patient
die
asthma
infiltr
lymphocyt
suggest
cellular
immun
respons
host
contribut
fatal
asthma
attack
studi
suggest
host
immun
respons
viru
import
induc
amplifi
airway
inflammatori
process
respons
asthma
therefor
although
relev
viral
nucleic
acid
demonstr
present
studi
unclear
believ
mechan
wherebi
persist
latent
viral
infect
might
contribut
chronic
airway
inflamm
deserv
investig
recent
studi
adenovir
infect
indic
latent
adenovir
dna
express
protein
capabl
amplifi
asymptomat
inflammatori
respons
one
capabl
caus
chronic
airway
obstruct
sever
laboratori
shown
protein
code
earli
adenovir
gene
dysregul
gene
express
interact
dnabind
site
transcript
factor
protein
also
interfer
function
suppressor
gene
retinoblastoma
gene
product
interfer
gene
express
bind
crebbind
protein
cbp
studi
establish
excess
amount
adenoviru
dna
present
lung
patient
obstruct
lung
diseas
protein
demonstr
human
lung
recent
studi
transfect
cell
shown
capabl
ofupregul
cell
challeng
work
hypothesi
latent
adenovir
infect
capabl
amplifi
cigarett
smokeinduc
airway
inflamm
present
smoker
produc
airway
obstruct
minor
patient
develop
complic
relev
hypothesi
asthma
remain
determin
macek
et
al
provid
interest
lead
show
children
bronchiol
subsequ
develop
steroidresist
asthma
frequent
show
evid
adenovir
hexon
protein
bal
fluid
rsv
parainfluenza
viru
piv
mump
viru
paramyxovirus
character
singlestrand
neg
polar
rna
genom
heavili
glycosyl
envelop
children
rsv
piv
respect
common
caus
acut
bronchiol
croup
addit
seriou
acut
lower
respiratori
tract
infect
epidemiolog
studi
clearli
establish
mani
children
develop
sequela
recurr
wheez
asthma
typic
context
allergi
anim
studi
report
experiment
rsv
piv
lower
respiratori
tract
infect
produc
increas
airway
respons
persist
week
month
acut
infect
histolog
examin
lung
rsvinfect
guinea
pig
resolut
acut
bronchiol
reveal
evid
chronic
inflamm
presenc
viral
protein
airway
chronic
airway
inflamm
mast
cell
hyperplasia
airway
wall
increas
express
cytokin
tgffl
also
report
sequela
piv
infect
rat
persist
airway
hyperrespons
observ
suggest
persist
viral
lung
infect
may
caus
structur
chang
airway
could
result
airway
hyperrespons
hallmark
asthma
viral
respiratori
tract
infect
may
also
play
indirect
role
pathogenesi
asthma
sever
line
evid
implic
viral
infect
trigger
initi
sensit
environment
allergen
suscept
children
experiment
anim
develop
rsvspecif
ige
antibodi
children
postbronchiol
wheez
consist
rsv
marker
allerg
diathesi
laboratorti
recent
report
airway
hyperrespons
produc
ovalbuminsensit
guinea
pig
exagger
acut
rsv
infect
part
mediat
virusinduc
increas
airway
epitheli
necrosi
observ
consist
paradigm
allerg
individu
suscept
viral
respiratori
tract
infect
develop
sever
symptom
infect
nonallerg
subject
better
understand
rel
import
direct
viral
damag
airway
indirect
viral
damag
via
allerg
mechan
could
lead
valuabl
new
strategi
treatment
prevent
viral
respiratori
infect
sequela
summari
result
show
widespread
preval
common
respiratori
viral
nucleic
acid
human
lung
tissu
obtain
patient
undergo
lung
resect
suggest
lung
may
serv
reservoir
viral
nucleic
acid
enter
host
via
respiratori
tract
postul
viral
residua
may
amplifi
airway
inflammatori
process
respons
asthma
chronic
obstruct
pulmonari
diseas
hyperrespons
viral
antigen
follow
respiratori
syncyti
viru
bronchiol
young
guinea
pig
eur
respir
schleimer
look
like
nfcb
increas
cell
also
suggest
gene
induc
cell
uniqu
site
mechan
increas
nfkb
nfkb
promot
uniqu
sequenc
anoth
mechan
hogg
nt
know
pathway
seem
involv
raz
think
paper
publish
natur
two
three
year
ago
claim
adenoviru
util
anoth
earli
gene
includ
protosom
process
one
icb
get
transloc
nfkb
activ
potenti
gelfand
activ
rasdepend
pathway
also
activ
rb
stressactiv
kinas
upregul
number
transcript
factor
includ
nfxb
hogg
particular
cell
nt
get
evid
upregul
gelfand
mention
lot
affect
cell
prolifer
well
cell
surviv
know
whether
chang
cultur
associ
signific
chang
either
apoptot
death
surviv
hogg
nt
know
obvious
import
thing
look
bienenstock
long
first
infect
still
found
tissu
hogg
controversi
peopl
believ
episom
disappear
cell
divid
dr
hayashi
group
tri
test
hypothesi
may
integr
host
dna
begun
graham
cell
cell
perman
transfect
adenovir
choos
primer
dna
allow
invers
pcr
techniqu
appli
amplifi
unknown
dna
adjac
preliminari
result
includ
sequenc
data
extend
across
junction
adenovir
human
dna
next
step
attempt
determin
whether
integr
human
lung
greater
challeng
much
wide
dispers
buss
stimuli
lp
also
mention
tnf
activ
cell
see
pattern
degre
cytokin
product
see
cytokin
hogg
answer
first
question
other
use
tnf
nt
list
show
give
one
look
search
literatur
show
produc
cell
effect
seen
icam
il
plattsmil
interpret
posit
pcr
rhinoviru
acut
asthmat
mean
patient
recent
infect
find
rna
place
patient
could
fool
actual
upregul
rhinoviru
event
hogg
surpris
colleagu
dr
hegel
shown
guinea
pig
rsv
persist
long
time
infect
low
level
replic
alveolar
macrophag
perhap
infect
persist
much
longer
think
low
level
replic
nt
effect
possibl
viral
rna
resist
rnaas
present
human
viral
nucleic
acid
hang
around
longer
period
done
best
make
sure
find
nt
artefact
believ
viral
nucleic
acid
get
anoth
question
although
bird
provid
reservoir
influenza
viru
reservoir
rsv
outbreak
known
human
lung
could
provid
reservoir
possibl
persist
low
level
replic
viru
raz
long
debat
immunolog
mechan
immunolog
memori
think
shown
constant
viral
presenc
probabl
respons
memori
benefici
keep
lung
system
shape
